126
Participants
Start Date
February 27, 2024
Primary Completion Date
April 30, 2026
Study Completion Date
April 30, 2026
AIRVO3 TM
A device that provides high flows of heated and humidified respiratory gases to patient who breath spontaneously. Patients will be treated with the device up to 15 days or until the occurrence of respiratory acidosis defined by pH\<7.35, whichever come first.
Standard therapy
Standard therapy depends on the acute respiratory failure etiology. Treatments will be administered at the investigator's discretion in accordance with the standard of care.
RECRUITING
Centre Hospitalier Intercommunal de Toulon- La Seyne sur Mer - Hôpital Sainte Musse, Toulon
RECRUITING
Centre Hospitalier Princesse Grace, Monaco
TERMINATED
Centre Hospitalier de Cannes, Cannes
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
OTHER